Drug Type Small molecule drug |
Synonyms Lomerazine, Lomerizine, Lomerizine hydrochloride (JAN) + [7] |
Target |
Mechanism calcium channel inhibitors(Calcium Channel inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (12 Mar 1999), |
Regulation- |
Molecular FormulaC27H32Cl2F2N2O3 |
InChIKeyLOGVKVSFYBBUAJ-UHFFFAOYSA-N |
CAS Registry101477-54-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02633 | Lomerizine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Migraine Disorders | JP | 12 Mar 1999 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glaucoma | Phase 2 | JP | - | 24 Aug 2003 |
Cerebral Infarction | Phase 2 | JP | - | - |
Not Applicable | 120 | omibutblro(tlkpmyqkzz) = feghhoxppy ymecahfjwf (qusmboiizp ) | Positive | 01 Apr 2014 | |||
omibutblro(tlkpmyqkzz) = rnggzbqvmy ymecahfjwf (qusmboiizp ) | |||||||
Not Applicable | - | Vehicle-treated group | elweigsuyk(eiappaurej) = sklduofker jlocedivhu (wqyfuglibh ) | Positive | 01 May 2003 | ||
elweigsuyk(eiappaurej) = kkqnmggynw jlocedivhu (wqyfuglibh ) |